Sjögren's syndrome: a systemic autoimmune disease

S Negrini, G Emmi, M Greco, M Borro… - Clinical and …, 2022 - Springer
Sjögren's syndrome is a chronic autoimmune disease characterized by ocular and oral
dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic …

GM-CSF: a promising target in inflammation and autoimmunity

KMC Lee, AA Achuthan, JA Hamilton - ImmunoTargets and therapy, 2020 - Taylor & Francis
The cytokine, granulocyte macrophage-colony stimulating factor (GM-CSF), was firstly
identified as being able to induce in vitro the proliferation and differentiation of bone marrow …

Bone loss, osteoporosis, and fractures in patients with rheumatoid arthritis: a review

P Fardellone, E Salawati, L Le Monnier… - Journal of Clinical …, 2020 - mdpi.com
Rheumatoid arthritis (RA) is often characterized by bone loss and fragility fractures and is a
frequent comorbidity. Compared with a matched population, RA patients with fractures have …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания: на перекрестке проблем тромбовоспаления и …

ЕЛ Насонов, ТВ Бекетова, ТМ Решетняк… - Научно …, 2020 - cyberleninka.ru
Воспаление и свертывание крови составляют основу защиты организма от
потенциально патогенных механических и биологических воздействий внешней и …

Targeting GM-CSF in inflammatory and autoimmune disorders

AA Achuthan, KMC Lee, JA Hamilton - Seminars in immunology, 2021 - Elsevier
Granulocyte macrophage-colony stimulating factor (GM-CSF) was originally identified as a
growth factor for its ability to promote the proliferation and differentiation in vitro of bone …

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled …

L Zeng, K Yang, Q He, X Zhu, Z Long, Y Wu, J Chen… - BMC medicine, 2024 - Springer
Background Previous randomized controlled trials (RCTs) suggested that gut microbiota-
based therapies may be effective in treating autoimmune diseases, but a systematic …

Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases

N Ciancio, M Pavone, SE Torrisi, A Vancheri… - Multidisciplinary …, 2019 - Springer
Abstract Introduction Connective Tissue Diseases (CTDs) are systemic autoimmune
conditions characterized by frequent lung involvement. This usually takes the form of …

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

E Nasonov, T Beketova, T Reshetnyak, A Lila… - 2021 - covid19.neicon.ru
Inflammation and coagulation are key basic mechanism of protection against all potentially
pathogenic mechanical and biological factors targeting human organism from inner and …

Interstitial pneumonia with autoimmune features: a single center prospective follow-up study

M Sebastiani, G Cassone, L De Pasquale, S Cerri… - Autoimmunity …, 2020 - Elsevier
Background and objective Recently the term “interstitial pneumonia with autoimmune
features”(IPAF) has been proposed to identify patients with interstitial lung disease and …

Implications of COVID-19 in pediatric rheumatology

ED Batu, S Özen - Rheumatology International, 2020 - Springer
Abstract COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2, is a
global public health issue threatening millions of lives worldwide. Although the infection is …